Education
About Us
Working with TipRanks
Follow Us
Rocket Doctor AI (AIRDF)
OTHER OTC:AIRDF
AIRDF Stock Chart & Stats
$0.54
--
Market closed
$0.54
--
Day’s Range― - ―
52-Week Range$0.08 - $0.71
Previous CloseN/A
VolumeN/A
Average Volume (3M)90.09K
Market Cap
$45.56M
Enterprise Value$62.52M
Total Cash (Recent Filing)$117.59K
Total Debt (Recent Filing)$613.46K
Price to Earnings (P/E)―
Beta0.73
Next Earnings
May 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding84,969,680
10 Day Avg. Volume67,406
30 Day Avg. Volume90,092
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)30.15
Price to Sales (P/S)2175.03
P/FCF Ratio-5.38
Enterprise Value/Market Cap1.37
Enterprise Value/Revenue119.38
Enterprise Value/Gross Profit133.55
Enterprise Value/Ebitda-7.16
Forecast
1Y Price Target
$1.54Price Target Upside185.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageLow debt-to-equity (~0.19) provides durable financial flexibility, reducing interest burden and preserving borrowing capacity. This structural advantage helps the company withstand execution risk while pursuing product rollouts or M&A without immediate refinancing pressure.
Strategic Partnerships & FundingAccess agreements covering ~13M members, a $2M NIH grant and an acquisition expand distribution, non-dilutive funding, and capabilities. Structurally, these moves broaden addressable market and build durable go-to-market channels that can support scaled revenue if execution follows.
Positive Gross ProfitPositive gross profit in 2024 indicates the platform can cover variable costs on delivered services, implying unit economics that can support sustainable margins as revenue scales. This is a fundamental building block for eventual profitability if fixed-cost growth is controlled.
Bears Say
Severe Cash BurnAccelerating cash burn (-$4.44M in 2024 vs -$0.74M in 2023) creates a structural funding risk over the medium term. Persistent outflows force management to secure capital, potentially diluting shareholders and diverting focus from long-term product and market development.
Tiny Revenue Base Vs Large LossesA 2024 revenue base of ~11k versus EBIT losses of -$6.1M shows the company is far from scale. Structurally, costs are materially ahead of demand, making sustained operating leverage unlikely without clear, durable revenue growth and execution on commercialization.
Equity Volatility / Balance Sheet StabilityHistorical negative equity and volatility signal prior dilution/accumulated losses, which can impair credibility with partners and lenders. Over the medium term this raises concerns about balance-sheet resilience and the company’s ability to fund scaling without recurring external support.
Rocket Doctor AI News
AIRDF FAQ
What was Rocket Doctor AI’s price range in the past 12 months?
Rocket Doctor AI lowest stock price was $0.08 and its highest was $0.71 in the past 12 months.
What is Rocket Doctor AI’s market cap?
Rocket Doctor AI’s market cap is $45.56M.
When is Rocket Doctor AI’s upcoming earnings report date?
Rocket Doctor AI’s upcoming earnings report date is May 04, 2026 which is in 77 days.
How were Rocket Doctor AI’s earnings last quarter?
Rocket Doctor AI released its earnings results on Dec 02, 2025. The company reported -$0.037 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.037.
Is Rocket Doctor AI overvalued?
According to Wall Street analysts Rocket Doctor AI’s price is currently Undervalued.
Does Rocket Doctor AI pay dividends?
Rocket Doctor AI does not currently pay dividends.
What is Rocket Doctor AI’s EPS estimate?
Rocket Doctor AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rocket Doctor AI have?
Rocket Doctor AI has 84,969,680 shares outstanding.
What happened to Rocket Doctor AI’s price movement after its last earnings report?
Rocket Doctor AI reported an EPS of -$0.037 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.667%.
Which hedge fund is a major shareholder of Rocket Doctor AI?
Currently, no hedge funds are holding shares in AIRDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rocket Doctor AI Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.54 (185.19% Upside)
$1.54 (185.19% Upside)
Blogger Sentiment
Bullish
AIRDF Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
37.23%
12-Months-Change
Fundamentals
Return on Equity
-207.53%
Trailing 12-Months
Asset Growth
2140.93%
Trailing 12-Months
Company Description
Rocket Doctor AI
Rocket Doctor AI Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
AIRDF Stock 12 Month Forecast
Average Price Target
$1.54
▲(185.19% Upside)